首页> 外文OA文献 >Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

【2h】

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

机译：婴儿白血病对肿瘤坏死因子相关凋亡诱导配体的抗性：对抗肿瘤免疫敏感性差的可能机制

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
T Inukai; X Zhang; M Goto; K Hirose; K Uno; K Akahane; A Nemoto; K Goi; H Sato; K Takahashi; H Honna; K Kagami; K Nakamoto; H Yagita; K Okumura; T Koyama-Okazaki; S Nakazawa; K Sugita;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity [J] . T Inukai, X Zhang, M Goto, Leukemia . 2006,第12期

机译：MLL重排的婴儿白血病对肿瘤坏死因子相关的凋亡诱导配体的耐药性：对抗肿瘤免疫敏感性较差的可能机制
2. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase [J] . Harikrishna Nakshatri, Susan E Rice, Poornima Bhat-Nakshatri Oncogene . 2004,第44期

机译：抗癌药单性酚通过持续激活c-Jun N端激酶来逆转乳腺癌细胞对肿瘤坏死因子相关凋亡诱导配体的抵抗力
3. Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. [J] . Kikuchi S, Nagai T, Kunitama M, Cancer science. . 2007,第12期

机译：活性FKHRL1通过产生肿瘤坏死因子相关的凋亡诱导配体，克服了慢性骨髓性白血病衍生细胞系对伊马替尼的耐药性。
4. Effect of Molecular Size of PEGylated tumor necrosis factor factor-related apoptosis apoptosis-inducing ligand(TRAIL) : T The Biological Activity and he Stability [C] . Tae Hyung Kim, Su Young Chae, Seung Min Byun, Annual meeting exposition of the Controlled Release Society . 2009

机译：PEG化肿瘤坏死因子相关细胞凋亡诱导配体（TRAIL）分子大小的影响生物学活性和稳定性
5. Impact of Hepatitis C Virus Core Protein on the Tumor Necrosis Factor Apoptosis-inducing Ligand Pathway in Peripheral Blood Mononuclear Cells [D] . Guy, Janelle. 2018

机译：丙型肝炎病毒核心蛋白对外周血单个核细胞中肿瘤坏死因子凋亡诱导配体途径的影响
6. Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines [O] . Takehiro Matsuda, Alex Almasan, Mariko Tomita, 2011

机译：抗Apo2配体（Apo2L）/肿瘤坏死因子相关的凋亡诱导配体（TRAIL）介导的细胞凋亡和Apo2L / TRAIL在人T细胞白血病病毒1型感染的T细胞系中的组成性表达
7. The mechanism of sensitivity and resistance of melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [O] . Kurbanov Bahtier 2010

机译：黑色素瘤细胞对肿瘤坏死因子相关的凋亡诱导配体（TRAIL）的敏感性和抗性机制
8. Modulators of Response to Tumor Necrosis-Related Apoptosis-Inducing Ligand (TRAIL) Therapy in Ovarian Cancer [R] . Behbakht, K. 2009

机译：肿瘤坏死相关凋亡诱导配体（TRaIL）治疗卵巢癌的调节因子

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

著录项

引文网络

相似文献

相关主题

期刊订阅